Table 3.
Multivariable Analyses of Risk Factors for LRTI in All Subjects
| Covariates | Categories | HR (95% CI) | P | Score Weight |
|---|---|---|---|---|
| Albumin | >3 | 1 | ||
| ≤3 | 1.65 (.99-2.76) | .056 | 11 | |
| Recipient CMV serostatus | - | 1 | ||
| + | 1.79 (1.17-2.73) | .007 | 12 | |
| Donor type | Autologous | 1 | ||
| Allogeneic/unrelated | 2.08 (1.22-3.58) | .008 | 14 | |
| Any previous HRV events | No | 1 | ||
| Yes | 1.67 (1.05-2.65) | .03 | 12 | |
| Lymphocyte count closest to HRV URTI, 106 cells/L | >100 | 1 | ||
| ≤100 | 2.39 (1.33-4.29) | .004 | 16 | |
| Recipient statin use | No | 1 | ||
| Yes | 2.06 (1.16-3.64) | .013 | 14 | |
| Steroid use before HRV URTI, mg/kg/day | 0 to <1 | 1 | ||
| ≥1 to <2 | 1.73 (.84-3.58) | .139 | 12 | |
| ≥2 | 2.91 (1.27-6.69) | .012 | 20 |